FDA NDC Directory · JSON-LD · Markdown

Humalog

NDC 0002-7516 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameInsulin lispro
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA020563
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsINSULIN LISPRO (100 [iU]/mL)
Marketing started19980220
Package count2

External sources

Source: openFDA. Public-domain (CC0).